The Efficacy and Safety of Venostan in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures

NARecruitingINTERVENTIONAL

Enrollment

290

Participants

Timeline

Start Date

April 16, 2025

Primary Completion Date

January 12, 2026

Study Completion Date

January 12, 2026

Conditions

Swelling/ Edema

Interventions

DRUG

Venostasin (horse chestnut seed extract tablets)

Venostasin (horse chestnut seed extract tablets) ，twice daily, 400 mg per dose, for 14 days

OTHER

standard treatment

Trial Locations (1)

RECRUITING

Beijing Jishuitan Hospital, Beijing

All Listed Sponsors

lead

Beijing Jishuitan Hospital

OTHER